Market Research Logo

Global Flow Cytometry Market - Segmented by Type of Product, Technology, Application, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)

Global Flow Cytometry Market - Segmented by Type of Product, Technology, Application, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)

The global flow cytometry market is expected to register a CAGR of 7.1% during 2018 to 2023 (the forecast period). Flow cytometry has evolved from a promising new technology to an indispensable tool, and its market is seeing a boom because of its application in the diagnosis of various disorders, like hematological disorders, malignancies, and various infections.

Use of Flow Cytometry in Stem Cell Research

Flow cytometry has been in use for decades by biologists studying hematopoietic stem cells to address the challenge of heterogeneity. New methods and tools are enabling researchers to employ this powerful technique to make key discoveries about other stem cell types and their respective lineages. Globally, the stem cell therapy market is expected to be worth USD 40 billion by 2020. Therefore, there is an expected potential for growth in the flow cytometry market for stem cell therapy in the coming years. Increase in funding from government and private organizations for stem cell research is also another factor that is expected to propel the market growth. Other factors, such as emergence and commercial application of new technologies in the field of flow cytometry and increasing applications of flow cytometry in clinical research, are increasing the growth of the market.

Expensive Equipment Hindering the Growth of the Market

Flow cytometers are expensive. The instrument cost can go as high as USD 350,000 depending on the parameters it can measure. The least expensive flow cytometers available now cost over USD 10,000 and measure to only two or three parameters. On top of that, assay reagent kits, filters, and other consumables add a few hundreds of dollars more to the overall expense. The expensive instrument and assay kits are hindering the growth of the flow cytometry market. Factors, such as lack of awareness about the potential benefits of flow cytometry techniques, are slowing the growth of the market.

United States to Lead the Market

The United States, in the North American region, dominates the market of flow cytometry due to the presence of supportive government policies for the development of advanced technologies for healthcare. North America is followed by Europe and Asia-Pacific. Asia-Pacific is expected to witness a lucrative growth rate during the forecast period.

Key Developments in the Market

  • January 2018 - Attune NxT Flow Cytometer system made multiparametric flow cytometry available to both new and experienced researchers.
  • January 2018 - Bio-Rad acquired RainDance Technologies.

Reasons to Purchase this Report
  • Current and future flow cytometry market outlook in the developed and emerging markets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3 months analyst support, along with the Market Estimate sheet (in excel)
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Use of Flow Cytometry in Stem Cell Research
6.1.2 Emergence and Commercial Application of New Technologies in the Field of Flow Cytometry
6.1.3 Increasing Applications of Flow Cytometry in Clinical Research
6.2 Market Restraints
6.2.1 Lack of Awareness About the Potential Benefits of Flow Cytometry Techniques
6.2.2 Expensive Equipment
6.3 Opportunities
6.3.1 Increasing Incidence of HIV and Cancer diseases
6.4 Key Challenges
6.4.1 High Maintenance and operational Cost of Devices
7. Market Segmentation
7.1 By Products
7.1.1 Instruments
7.1.2 Flourophores
7.1.3 Kits & Reagents
7.1.4 Software
7.1.5 Others
7.2 By Technology
7.2.1 Cell-based Flow Cytometry
7.2.2 Bead-based Flow Cytometry
7.3 By Application
7.3.1 Oncology
7.3.2 Drug Discovery
7.3.3 Disease Diagnosis
7.3.4 Stem Cell Therapy
7.3.5 Organ Transplantation
7.3.6 Hematology
7.3.7 Others
7.4 By End User
7.4.1 Hospitals & Clinics
7.4.2 Academia & Research Institutions
7.4.3 Pharmaceutical & Biotechnology Companies
7.4.4 Others
7.5 By Geography
7.5.1 North America United States Canada Mexico
7.5.2 Europe France Germany United Kingdom Italy Spain Rest of Europe
7.5.3 Asia-Pacific China Japan India Australia & New Zealand South Korea Rest of Asia-Pacific
7.5.4 Middle East & Africa GCC South Africa Rest of the Middle East & Africa
7.5.5 South America Brazil Argentina Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Beckman Coulter
9.2 Becton Dickinson
9.3 Bio-Rad Laboratories
9.4 EMD Millipore
9.5 Life Technologies
9.6 Luminex Corporation
9.7 Miltenyi Biotech
9.8 Sysmex Partec GmbH
9.9 Agilent Technologies
* List Not Exhaustive
10. Future of the Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report